Prelude Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-45,236
Closed -$1.88M 1466
2023
Q2
$1.88M Sell
45,236
-10,480
-19% -$430K 0.12% 211
2023
Q1
$2.3M Buy
+55,716
New +$2.38M 0.14% 184
2022
Q4
Sell
-9,252
Closed -$405K 1752
2022
Q3
$405K Buy
+9,252
New +$448K 0.01% 737
2021
Q3
Sell
-7,234
Closed -$490K 2118
2021
Q2
$490K Buy
7,234
+545
+8% +$37.2K 0.01% 978
2021
Q1
$439K Buy
+6,689
New +$401K 0.01% 963
2020
Q3
Sell
-134
Closed -$7K 2497
2020
Q2
$7K Sell
134
-357
-73% -$20.6K ﹤0.01% 1657
2020
Q1
$25K Sell
491
-711
-59% -$47.7K ﹤0.01% 937
2019
Q4
$93K Buy
+1,202
New +$84.9K ﹤0.01% 1141
2018
Q4
Sell
-71
Closed -$5K 2258
2018
Q3
$5K Sell
71
-143
-67% -$9.1K ﹤0.01% 1635
2018
Q2
$11K Sell
214
-4,249
-95% -$223K ﹤0.01% 1476
2018
Q1
$233K Buy
4,463
+3,892
+682% +$197K 0.02% 648
2017
Q4
$33K Sell
571
-2,822
-83% -$160K ﹤0.01% 1027
2017
Q3
$188K Buy
3,393
+2,480
+272% +$164K 0.02% 675
2017
Q2
$70K Buy
+913
New +$68.2K 0.01% 891
2016
Q3
Sell
-128
Closed -$8K 1881
2016
Q2
$8K Sell
128
-4,372
-97% -$236K ﹤0.01% 1418
2016
Q1
$219K Buy
4,500
+1,500
+50% +$68.1K 0.03% 525
2015
Q4
$162K Buy
+3,000
New +$153K 0.03% 650
2015
Q1
Sell
-2,000
Closed -$94K 2258
2014
Q4
$94K Sell
2,000
-1,900
-49% -$79.2K 0.01% 1029
2014
Q3
$136K Buy
3,900
+500
+15% +$17.8K 0.02% 911
2014
Q2
$121K Buy
3,400
+1,900
+127% +$65K 0.02% 1022
2014
Q1
$58K Buy
+1,500
New +$55.1K 0.01% 1247
2013
Q4
Sell
-90
Closed -$2K 1985
2013
Q3
$2K Buy
+90
New +$2.21K ﹤0.01% 1686

Other funds holding NUVA

Prelude Capital Management's NUVA Position: Q3 2023 in Review

Prelude Capital Management sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 45,236 shares — an estimated $1.88M sold.

Prelude Capital Management first reported a position in NUVA in Q3 2013 and held it in 22 quarters. The position peaked at $2.3M in Q1 2023. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Prelude Capital Management reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Prelude Capital Management sold 45,236 NuVasive, Inc. shares in Q3 2023, an estimated $1.88M.
  • Prelude Capital Management first reported a position in NuVasive, Inc. in Q3 2013 and held it in 22 quarters.
  • Prelude Capital Management's NuVasive, Inc. position peaked at $2.3M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.